• Home

Related articles

  • Cost-effectiveness of elimination of HPV-cancers

    M Jit

  • Systematic review of studies on HPV type-replacement after generalized vaccination

    D Mesher

  • Screening of HPV vaccinated women

    E Franco

  • Elimination of cervical cancer from developing countries

    S Franceschi

  • Costs and benefits of combined programs of screening and vaccination

    P Nieminen

  • Overall protection generated by gender-neutral HPV vaccination

    M Lehtinen

  • Elimination of cervical cancer from Europe

    X Bosch

  • From disease elimination to elimination of the oncogenic HPVs

    P Nieminen

  • HPV self-sampling is here

    P Snijders

  • The frequency of HPV infection worldwide

    L Bruni

  • IPVS Statement on HPV Vaccination of Immunocompromised Hosts

    Garland & IPVS Policy Committee

  • Tracking the impact of HPV vaccination on infection prevalence to measure vaccination program success

    D Machalek, K Sharma, J Kaldor

  • HPV infections in High-Risk groups

    S Krüger

  • FACT SHEET: FRANCE www.hpvcentre.net

    C Clavel, G Albero, L Bruni

  • Global vaccine uptake and projected cervical cancer disease reductions

    L Bruni

  • FACT SHEET: MEXICO www.hpvcentre.net

    E Lazcano-Ponce, J Salmeron
    G Albero, L Bruni

  • FACT SHEET: COLOMBIA www.hpvcentre.net

    V. Rangel, R. Murillo, G. Albero, L. Bruni

  • HPV-FASTER: searching for strategies to serve the cervical cancer elimination campaign in COVID-19 times

    C Robles, MA Pavón, M Díaz Sanchís, X Bosch

  • FACT SHEET: WESTERN AFRICA www.hpvcentre.net

    K. Effah, G Albero, L Bruni

  • Cervical cancer and HIV

    LF Tanaka, D Stelzle, SJ Klug

  • HOME
  • Published material
  • Remembering our colleagues
  • About us
  • Contact us

Login

Change email Change password Activate service

Did you forget your password?

Do you want to subscribe?

Legal noticePrivacy Policy
Copyright © 2023 HPV World All rights reserved